Study Of Costa Rican Women Shows HPV Vaccine Of Little Benefit To Women Over Age 40
Main Category: Cervical Cancer / HPV VaccineArticle Date: 26 Feb 2010 - 5:00 PDT
'Study Of Costa Rican Women Shows HPV Vaccine Of Little Benefit To Women Over Age 40'
| Patient / Public: | ![]() |
3 (2 votes) |
| Healthcare Prof: | ![]() |
Women older than age 40 are not likely to receive a substantial benefit from vaccination against the human papillomavirus, according to a study published in the Journal of the National Cancer Institute, the New York Times reports. Although HPV infection is more common in older women, the study found that the rate of newly detected cases declined with age, from 35% of cases in women ages 18 through 25 to 13.5% of cases in women age 42 and older. Study author Cecilia Rodriguez of the Costa Rica-based Inciensa Foundation said, "Because the HPV vaccine can only prevent infections, and these women are not getting that many new infections, the potential benefit of HPV vaccination among older women is very limited" (Rabin, New York Times, 2/24).
Merck's HPV vaccine, Gardasil, helps block four of the most common HPV strains -- two types that cause 70% of cervical cancer cases and two other types that cause 90% of genital warts cases. The vaccine is approved by FDA for use in girls and women ages nine through 26. Merck is seeking FDA approval to market Gardasil for cervical cancer and genital warts prevention in women up to age 45, and it recently presented the agency with data from a study the company believes shows that the vaccine is effective for women ages 24 through 45 (Women's Health Policy Report, 2/17).
Rodriguez's study, which was supported by NIH, followed more than 9,000 Costa Rican women ages 19 through 97. The women were screened for carcinogenic HPV infections and precursors to cervical cancer. Rodriguez said that in older women, cervical cancer often develops decades after initial infection with a carcinogenic virus. Across all age groups, new infections typically cleared up without treatment within about two years (New York Times, 2/24).
Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women's Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women's Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company.
© 2010 The Advisory Board Company. All rights reserved.
Visit our cervical cancer / hpv vaccine section for the latest news on this subject.
MLA
25 May. 2012. <http://www.medicalnewstoday.com/releases/180529.php>
APA
http://www.medicalnewstoday.com/releases/180529.php.
Please note: If no author information is provided, the source is cited instead.
Add Your Opinion On This Article
'Study Of Costa Rican Women Shows HPV Vaccine Of Little Benefit To Women Over Age 40'Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




